Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease

Volume: 52, Issue: 10-11, Pages: 837 - 844
Published: Jan 1, 2021
Abstract
Hyperuricemia predicts the development of chronic kidney disease (CKD) and metabolic complications, but whether it has a causal role has been controversial. This is especially true given the 2 recently conducted randomized controlled trials that failed to show a benefit of lowering uric acid in type 1 diabetes-associated CKD and subjects with stage 3–4 CKD. While these studies suggest that use of urate-lowering drugs in unselected patients is...
Paper Details
Title
Mini Review: Reappraisal of Uric Acid in Chronic Kidney Disease
Published Date
Jan 1, 2021
Volume
52
Issue
10-11
Pages
837 - 844
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.